Sheena Niese, DPM
Podiatrist · Alliance, OHNPI 1902271596
Payments from drug & device makers
Across 39 payments — averaging $100.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$3K
- Smith+Nephew$182
- Stryker$133
- Nevro Corp.$52
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$45
- Bioventus LLC$43
- plus $240 from 12 others
What the payments were for
- Travel & lodging$2,40261%
- Food & beverage$1,53739%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 11 | $3,243 |
| Smith+Nephew | 6 | $182 |
| Stryker | 2 | $133 |
| Nevro Corp. | 3 | $52 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $45 |
| Bioventus LLC | 2 | $43 |
| Paratek Pharmaceuticals, Inc. | 2 | $39 |
| Curonix LLC | 1 | $37 |
| Mimedx Group, Inc. | 1 | $37 |
| Integra Lifesciences Corporation | 1 | $25 |
| Organogenesis Inc. | 1 | $18 |
| Averitas Pharma Inc. | 1 | $14 |
| Treace Medical Concepts, Inc. | 1 | $13 |
| Kerecis Limited | 1 | $12 |
| Orthofix Medical, Inc. | 1 | $12 |
| Zimmer Biomet | 1 | $12 |
| Celularity Inc. | 1 | $12 |
| Lifenet Health | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$1,611
- Portfolio$1,595
How this compares
$3,938 in reported general payments places this provider in the 75th percentile of 397 podiatrist providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 46 | $1,087 |
| Ketoconazole | 26 | $752 |
| Diclofenac Sodium | 14 | $426 |
| Diclofenac Sodium ErDiclofenac Sodium | 11 | $292 |
| Mupirocin | 25 | $136 |
| Doxycycline Hyclate | 16 | $134 |
| Methylprednisolone | 20 | $80 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Alliance
- Leslie NiehausAlliance$8K
- Mark HardyAvon$2.1M
- Lawrence DidomenicoBoardman$1.5M
- Ralph NapolitanoNew Albany$494K
- Thomas GronerNiles$193K
- Michael MaierCleveland$120K
- Daniel LoganGahanna$108K
- Eric StortsLondon$101K
- Howard KimmelBrookpark$67K
- Richard SchillingColumbus$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.